Literature DB >> 12724808

[Increased skin pigmentation in patients with chronic renal failure undergoing hemodialysis infected with the hepatitis C virus].

Humberto Kukhyun Choi1, Fernando Saldanha Thomé, Tobias Orlandini, Elvino Barros.   

Abstract

BACKGROUND: Skin pigmentation is commonly found in patients with chronic renal failure (CRF). This symptom is also one of the most evident features of Porphyria Cutanea Tarda (PCT). Hepatitis C virus (HCV) is an important precipitating agent of this disease, which has been described in patients undergoing hemodialysis (HD). In this paper, we intend to evaluate the prevalence of difuse skin hyperpigmentation in patients with CRF infected with the HCV.
METHODS: We developed a transversal study with 47 patients (mean age 50,35 + 15,16 years; 31 men and 16 women) who were on hemodialysis in march of 2001 at the Unit of Dialysis of Hospital de Cl nicas de Porto Alegre. Patients were divided in two groups: group 1, anti-HCV positives (n=17), and group 2, anti-HCV negatives (n=30).
RESULTS: The prevalence of skin hyperpigmentation related to HD was 36,2% (n=17). There were 10 patients (58,8%) in group 1 and 7 (23,3%) in group 2 (Odds Ratio of 2,52 and 95% Confidence Interval of 1,18-5,4; p<0,05). Among patients who have undergone HD for until 36 months (n=24), 6 were anti-HCV positive and 3 of tham (50%) mentioned skin pigmentation (OR of 9,0 and 95%CI of 1,1-71,0; p<0,05). Patients from group 2 who referenced the symptom have been on HD for a longer period than those who did not (63,85 + 11,9 vs. 29,3 + 4,71 months; p<0,05).
CONCLUSIONS: HCV infection was associated with increased skin hyperpigmentation in patients with CRF undergoing HD. Time on treatment was also associated with this signal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724808     DOI: 10.1590/s0104-42302003000100029

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  2 in total

1.  Cutaneous abnormalities in patients with end stage renal failure on chronic hemodialysis. A study of 458 patients.

Authors:  Abderrahmen Masmoudi; Mounira Hajjaji Darouiche; Haifa Ben Salah; Mohamed Ben Hmida; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2014-12-31

2.  Persistently high hepatitis C rates in haemodialysis patients in Brazil [a systematic review and meta-analysis].

Authors:  Roberta Pereira Niquini; Jurema Corrêa da Mota; Leonardo Soares Bastos; Diego da Costa Moreira Barbosa; Juliane da Silva Falcão; Paloma Palmieri; Patrícia Martins; Livia Melo Villar; Francisco I Bastos
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.